NCT01189175View on ClinicalTrials.gov

Study in Healthy Male Subjects to Investigate Whether Ketoconazole Affects Plasma Exposure of BI 113823

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

September 30, 2010

Conditions
Healthy
Interventions
DRUG

BI 113823 + Ketokonazole

5 days ketokonazole with single oral dose of BI 113823 on day 3

DRUG

BI 113823

single oral dose

Trial Locations (1)

Unknown

1272.5.1 Boehringer Ingelheim Investigational Site, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY